Showing results (321-330 of 358) with videos related to
Sort By:
Pageof 36
Antimicrobial Agents and Chemotherapy|August 30, 2021
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South AfricaZubeida Salaam-Dreyer, Elizabeth M Streicher, Frederick A Sirgel, et al.Journal of Clinical Microbiology|February 16, 2022
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort StudyHelen Cox, Galo A Goig, Zubeida Salaam-Dreyer, et al.The Lancet. Infectious Diseases|December 18, 2018
Transmission of drug-resistant tuberculosis in HIV-endemic settingsPalwasha Y Khan, Tom A Yates, Muhammad Osman, et al.Journal of Medicinal Chemistry|August 20, 2021
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in Mycobacterium tuberculosisLutete Peguy Khonde, Rudolf Müller, Grant A Boyle, et al.Research Square|April 1, 2025
Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputumLoren Rockman, Shima Abdulgader, Stephanie Minnies, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2025
Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputumLoren Rockman, Shima M Abdulgader, Stephanie Minnies, et al.The Journal of Antimicrobial Chemotherapy|July 10, 2024
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugsMarie Wijk, Kamunkhwala Gausi, Samantha Malatesta, et al.American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Efficacy and Safety of Higher Doses of Levofloxacin for MDR-TB: A Randomized Placebo-controlled Phase 2 TrialPatrick Pj Phillips, Charles A Peloquin, Timothy R Sterling, et al.Research Square|April 22, 2024
Latent tuberculosis infection is associated with an enrichment of short chain fatty acid producing bacteria in the stool of women living with HIVSuventha Moodley, Elouise Kroon, Charissa C Naidoo, et al.The Lancet. Microbe|November 12, 2021
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology studyHelen Cox, Zubeida Salaam-Dreyer, Galo A Goig, et al.Pageof 36